Sepsis & infection

Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial

JAMAPublished Randomised controlled trial

An erratum to this article was published (JAMA, 13 Jan 2026 ↗)

Authors' conclusion

Care guided by measurement of PCT reduces antibiotic duration safely compared with standard care, but CRP does not. All-cause mortality for CRP was inconclusive.

Study context

Population
Critically ill adults (≥18 years) in 41 UK National Health Service (NHS) ICUs requiring critical care within 24 hours of starting IV antibiotics for suspected sepsis, likely to continue antibiotics ≥72 hours
Participants
2,760 adults · 41 UK NHS ICUs
Comparison
Daily procalcitonin (PCT)-guided or daily C-reactive protein (CRP)-guided protocol vs standard care for antibiotic duration
  • PCTn = 918
  • CRPn = 924
  • Standard caren = 918reference
Primary endpoint
Total duration of antibiotics (effectiveness) and all-cause mortality (safety)
Follow-up
Up to 28 days
Methodological detailsmulticentre, intervention-concealed, non-inferiority (mortality)
  • Multicentre
  • Intervention-concealed
  • Non-inferiority (mortality)

Primary result

As reported in the abstract

Antibiotic duration from randomization to 28 days
Each group vs standard careMean difference, days (95% CI)P value
PCT
0.88(0.19–1.58)
P = 0.01
Each group vs standard careMean difference (95% CI)P value
CRP
0.09(−0.60 to 0.79)
P = 0.79

Secondary outcomes

OutcomePCTCRPStandard careAbsolute difference (95% CI)P value
All-cause mortality up to 28 days (primary safety outcome)PCT vs Standard care · noninferior; margin 5.4%20.9%21.1%19.4%1.57 (−2.18 to 5.32)P = 0.02
All-cause mortality up to 28 days (primary safety outcome)CRP vs Standard care · inconclusive1.69 (−2.07 to 5.45)P = 0.03
  • All-cause mortality up to 28 days (primary safety outcome): noninferiority margin 5.4%
  • All-cause mortality up to 28 days (primary safety outcome): denominators: standard care 878, PCT 879, CRP 874

Original publication

Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial. JAMA. Published 25 February 2025. doi:10.1001/jama.2024.26458

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.